{
    "organizations": [],
    "uuid": "b411409f00ad1bf9f0d96ba1f1ce467e30db8c40",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-shanghai-fosun-pharmaceutical-gets/brief-shanghai-fosun-pharmaceutical-gets-approval-to-issue-medium-term-notes-commercial-paper-idUSH9N1RX01R",
    "ord_in_thread": 0,
    "title": "BRIEF-Shanghai Fosun Pharmaceutical Gets Approval To Issue Medium-Term Notes, Commercial Paper",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": " Shanghai Fosun Pharmaceutical Group Co Ltd:\n* SAYS IT GETS APPROVAL TO ISSUE 5.0 BILLION YUAN ($793.21 million) MEDIUM-TERM NOTES, 5.0 BILLION YUAN COMMERCIAL PAPER Source text in Chinese: bit.ly/2K6qEDz Further company coverage: ($1 = 6.3035 Chinese yuan renminbi) (Reporting by Hong Kong newsroom)\n ",
    "published": "2018-04-24T18:57:00.000+03:00",
    "crawled": "2018-04-25T14:36:23.007+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "shanghai",
        "fosun",
        "pharmaceutical",
        "group",
        "co",
        "ltd",
        "say",
        "get",
        "approval",
        "issue",
        "billion",
        "yuan",
        "million",
        "note",
        "billion",
        "yuan",
        "commercial",
        "paper",
        "source",
        "text",
        "chinese",
        "company",
        "coverage",
        "chinese",
        "yuan",
        "renminbi",
        "reporting",
        "hong",
        "kong",
        "newsroom"
    ]
}